High perceived stress is linked to afternoon cortisol levels and greater symptom distress in patients with localized prostate cancer

Cancer Nursing

Volumn 34, Issue 6, 2011, Pages 470-478

  Hsiao, Chao Pin ^a   Moore, Ida M ^b   Insel, Kathleen C ^b   Merkle, Carrie J ^b  

^a NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Perceived stress; Prostate cancer; Radiation therapy; Radical prostatectomy; Salivary cortisol; Stress; Symptom distress; Symptoms

Indexed keywords

HYDROCORTISONE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CIRCADIAN RHYTHM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRESS SYNDROME; GASTROINTESTINAL DISEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUESTIONNAIRE; SALIVA ANALYSIS; SELF REPORT; SEXUAL DYSFUNCTION; URINARY DYSFUNCTION;

AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITATIVE RESEARCH; QUALITY OF LIFE; RADIOTHERAPY; SALIVA; STRESS, PSYCHOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 80255129412     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e31820a5943     Document Type: Article

References (49)

1. World Health Organization. Internal Agency for Research on Cancer. IRAC Web site. http://www.iarc.fr/. Accessed October 10, 2010.
2. American Cancer Society. Cancer Facts & Figures. Hagerstown, MD: Lippincott Williams & Wilkins; 2009.
3. Damber JE, Aus G. Prostate cancer. Lancet. 2008;371(9625):1710-1721. (Pubitemid 351671887)
4. Krahn MD, Bremner KE, Tomlinson G, Naglie G. Utility and healthrelated quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy. Prostate Cancer Prostatic Dis. 2009; 12(4):361-368.
5. Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Management of complications of prostate cancer treatment. CA Cancer J Clin. 2008;58(4):196-213.
6. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10-30. (Pubitemid 40310185)
7. Henderson A, Laing RW, Langley SE. Improvement in urinary symptoms after radical prostatectomy: a prospective evaluation of flow rates and symptom scores. BJU Int. 2004;93(1):180-181. (Pubitemid 38112993)
8. Hernandez J, Thompson IM. Diagnosis and treatment of prostate cancer. Med Clin North Am. 2004;88(2):267-279. (Pubitemid 38231009)
9. Clark JA, Talcott JA. Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care. 2001;39(10):1118-1130. (Pubitemid 33691385)
10. Harlan LC, Potosky A, Gilliland FD, et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst. 2001;93(24):1864-1871. (Pubitemid 34048653)
11. Goodell TT, Nail LM. Operationalizing symptom distress in adults with cancer: a literature synthesis. Oncol Nurs Forum. 2005;32(2):E42-E47.
12. Maddock C, Pariante CM. How does stress affect you? An overview of stress, immunity, depression and disease. Epidemiol Psichiatr Soc. 2001; 10(3):153-162. (Pubitemid 33150889)
13. Spiegel D, Sephton SE. Psychoneuroimmune and endocrine pathways in cancer: effects of stress and support. Semin Clin Neuropsychiatry. 2001; 6(4):252-265.
14. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29(4):448-474. (Pubitemid 38121602)
15. Vedhara K, Tuinstra J, Miles JN, Sanderman R, Ranchor AV. Psychosocial factors associated with indices of cortisol production in women with breast cancer and controls. Psychoneuroendocrinology. 2006;31(3):299-311. (Pubitemid 43261649)
16. Van Eck MM, Nicolson NA. Perceived stress and salivary cortisol in daily life. Ann Behav Med. 1994;16(3):221-227. (Pubitemid 24280826)
17. Vedhara K, Fox JD,Wang EC. The measurement of stress-related immune dysfunction in psychoneuroimmunology. Neurosci Biobehav Rev. 1999; 23(5):699-715. (Pubitemid 29282021)
18. Pruessner JC, Hellhammer DH, Kirschbaum C. Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med. 1999;61(2):197-204. (Pubitemid 29168650)
19. Lasikiewicz N, Hendrickx H, Talbot D, Dye L. Exploration of basal diurnal salivary cortisol profiles in middle-aged adults: associations with sleep quality and metabolic parameters. Psychoneuroendocrinology. 2008; 33(2):143-151.
20. al-Abany M, Helgason AR, Cronqvist AK, Svensson C,Wersall P, Steineck G. Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields. Acta Oncol. 2002;41(6):532-542. (Pubitemid 36067294)
21. Salimatrics I. HS-cortisol high sensitivity salivary cortisol enzyme immunoassay kit. Salimatrics Web site. http://salimetrics.com/index.html. Accessed August 17, 2008.
22. Stewart J, Seeman T. Salivary cortisol measurement. UCSF Web site. http://www.macses.ucsf.edu/Research/Allostatic/notebook/salivarycort. html. Accessed January 15, 2008.
23. Haussmann MF, Vleck CM, Farrar ES. A laboratory exercise to illustrate increased salivary cortisol in response to three stressful conditions using competitive ELISA. Adv Physiol Educ. 2007;31(1):110-115.
24. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-396.
25. Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, eds. The Social Psychology of Health: Claremont Symposium on Applied Social Psychology. Newbury Park, CA: Sage; 1988:31-67.
26. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003;28(7):916-931. (Pubitemid 36936799)
27. Smyth JM, Ockenfels MC, Gorin AA, et al. Individual differences in the diurnal cycle of cortisol. Psychoneuroendocrinology. 1997;22(2):89-105. (Pubitemid 27236732)
28. Stone AA, Schwartz JE, Smyth J, et al. Individual differences in the diurnal cycle of salivary free cortisol: a replication of flattened cycles for some individuals. Psychoneuroendocrinology. 2001;26(3):295-306. (Pubitemid 32144733)
29. Ice GH, Katz-Stein A, Himes J, Kane RL. Diurnal cycles of salivary cortisol in older adults. Psychoneuroendocrinology. 2004;29(3):355-370. (Pubitemid 37487953)
30. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000; 92(12):994-1000. (Pubitemid 30469965)
31. Mormont MC, Levi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997;70(2):241-247. (Pubitemid 27107423)
32. Chrousos GP, Gold PW. A healthy body in a healthy mindVand vice versaVthe damaging power of Buncontrollable[ stress. J Clin Endocrinol Metab. 1998;83(6):1842-1845. (Pubitemid 28496303)
33. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry. 1995;52(2):89-99.
34. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev. 1986;7(3): 284-301.
35. Fekedulegn DB, Andrew ME, Burchfiel CM, et al. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom Med. 2007;69(7):651-659. (Pubitemid 47463823)
36. Lasikiewicz N, Hendrickx H, Talbot D, Dye L. Exploration of basal diurnal salivary cortisol profiles in middle-aged adults: associations with sleep quality and metabolic parameters. Psychoneuroendocrinology. 2008; 33(2):143-151.
37. Buron C, Le Vu B, Cosset JM, et al. Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study. Int J Radiat Oncol Biol Phys. 2007;67(3): 812-822. (Pubitemid 46215887)
38. Bhatnagar V, Stewart ST, Huynh V, Jorgensen G, Kaplan RM. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment. Prostate Cancer Prostatic Dis. 2006;9(2):136-146. (Pubitemid 43970962)
39. Clark JA, Inui TS, Silliman RA, et al. Patients' perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol. 2003;21(20): 3777-3784. (Pubitemid 46606232)
40. Clark JA, Bokhour BG, Inui TS, Silliman RA, Talcott JA. Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Med Care. 2003;41(8):923-936.
41. Korfage IJ, Essink-Bot ML, Borsboom GJ, et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer. 2005;116(2):291-296. (Pubitemid 40967268)
42. Eller LS, Lev EL, Gejerman G, et al. Prospective study of quality of life of patients receiving treatment for prostate cancer. Nurs Res. 2006; 55(2 suppl):S28-S36. (Pubitemid 44620334)
43. Litwin MS, Gore JL, Kwan L, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007;109(11):2239-2247. (Pubitemid 46801553)
44. Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol. 2003;21(21): 3979-3986. (Pubitemid 46606212)
45. Penson DF. Quality of life after therapy for localized prostate cancer. Cancer J. 2007;13(5):318-326.
46. Burnett AL, Aus G, Canby-Hagino ED, et al. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol. 2007; 178(2):597-601. (Pubitemid 47030514)
47. Eton DT, Lepore SJ, Helgeson VS. Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors. Cancer. 2001;92(6):1451-1459. (Pubitemid 32947829)
48. Joseph HJ, Thibault GP, Ruttle-King J. Perceived stress and quality of life among prostate cancer survivors. Mil Med. 2006;171(5):425-429. (Pubitemid 43726380)
49. Williamson A. Using self-report measures in neurobehavioural toxicology: can they be trusted? Neurotoxicology. 2007;28(2):227-234.